ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 108

Disparity Between Sonographic and Clinical Criteria of Remission in Psoriasis Arthritis

Christian Dejaco1, Rusmir Husic2, Judith Gretler3, Winfried B. Graninger4 and Josef Hermann2, 1Rheumatology, Southend University Hospital, Westcliff-on-Sea, United Kingdom, 2Rheumatology, Medical University Graz, Graz, Austria, 3Med Univ Klinik Graz, Auenbruggerplatz 15, Graz, Austria, 4Internal medicine/Rheumatology and Immunology, Medical University Graz, Graz, Austria

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Psoriatic arthritis, remission and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases: Ultrasound, Nuclear Medicine and Fluorescence Imaging

Session Type: Abstract Submissions (ACR)

Background/Purpose: To compare ultrasound and clinical definitions of remission in psoriasis arthritis (PsA).

Methods: Prospective study of 70 consecutive PsA patients [mean age 51.1 (±SD 11.6) years, 30% female, median disease duration 7.0 (range 0-44.7) years]. Clinical and ultrasound examination was performed at 68 joints and 14 entheses (lateral epicondyle, triceps insertion, quadrizeps insertion, proximal and distal insertion of patellar ligament, Achilles tendon, plantar fascia), and Disease Activity index for PSoriatic Arthritis (DAPSA),  composite psoriatic disease activity index (CPDAI), HAQ and PASI were calculated. The following clinical definitions of remission were applied: DAPSA ≤3.3, CPDAI (joint, entheses and dactilytis domains) =0 or a Boolean definition with a score ≤1 in all of the following categories: tender joints (TJ), swollen joints (SJ), CRP, patient’s (PGA) and evaluator´s global assessment (EGA), enthesitis and dactylitis. Sonography was performed by two rheumatologists blinded to clinical data using an ESAOTE Twice ultrasound device. Power Doppler (PD) signals were  graded from 0 to 3. The presence of perisynovitis and tenosynovitis was also recorded. Ultrasound remission was defined by a PD-score of 0 at joints, entheses and tendons.

Results: Fifteen (21.4%), 12 (17.1%) and 11 (15.7%) PsA patients were in remission according to the CPDAI, DAPSA and the Boolean definitions. A lower prevalence of PD signals in at least one joint or tendon was found in patients in remission according to DAPSA (58.3% vs. 84.5%, p=0.039 and 8.3% vs. 38.6%,p=0.043, respectively) and the Boolean definition (54.5% vs. 84.7%, p=0.022 and 9.1% vs. 37.9%, p=0.06, respectively) whereas the prevalence of active synovitis was similar in inactive and active disease groups according to CPDAI (66.7% vs. 83.6%, n.s.). Tenosynovitis tended to be more prevalent in cases with active disease according to CPDAI compared to patients in remission (38.9% vs. 13.3%, p=0.06). Frequencies of active enthesitis and perisynovitis were similar in groups with active and inactive disease according to CPDAI, DAPSA and the Boolean definitions.

Three (4.3%) patients had no PD-signal in joints, entheses and tendons. Comparing patients with PD-score=0 [n=14 (20%)] and PD-score≥1 at joints we found a lower number of SJ [0 (0-4) vs. 1 (0-15), p=0.007] and lower ESR [6.5 (1.0-17.0) vs 10.0 (1.0-74.0), p=0.049] among patients with inactive disease. CPDAI, DAPSA, TJ, CRP, PGA; EGA and HAQ were similar in both groups.

Patients without PD-signals at tendons [n=46 (65.7%)] had lower DAPSA [9.9 (0.1 -70.2) vs. 17.4 (0.2 -60.8), p=0.012], lower PGA [30 (0-80) vs. 40 (0-80), p=0.024], lower CRP [2.0 (0-20.3) vs. 4.8 (0.6-49.5), p=0.013] and lower ESR [6.0 (1.0-47.0) vs. 18.0 (5.0-74.0), p<0.001] compared to patients with active tenosynovitis.

Patients without PD signals at entheses [n=27 (38.6%)] did not differ from patients with active disease regarding clinical scores and laboratory measures.

Conclusion: Our data demonstrate a disparity between ultrasound and clinical definitions of remission in PsA. DAPSA and Boolean based definitions of remission are closer to ultrasound defined remission than a CPDAI based definition.


Disclosure:

C. Dejaco,
None;

R. Husic,
None;

J. Gretler,
None;

W. B. Graninger,
None;

J. Hermann,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/disparity-between-sonographic-and-clinical-criteria-of-remission-in-psoriasis-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology